Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia. 2004

Elisabet Lloveras, and Isabel Granada, and Lurdes Zamora, and Blanca Espinet, and Lourdes Florensa, and Carles Besses, and Marisol Xandri, and Maria Encarnación Pérez-Vila, and Fuensanta Millà, and Soledad Woessner, and Francesc Solé
Laboratori de Citogenètica i Biologia Molecular, Servei de Patologia, Hospital del Mar-IMAS, Passeig marítim 25-29, 08003 Barcelona, Spain. e0037@imas.imim.es

We report cytogenetic results in a series of 60 patients affected with multiple myeloma (MM) and plasma cell leukemia (PCL) and compare the results with those previously reported. In our series, a total of 41% of MM patients and 71% of PCL patients displayed chromosome abnormalities. To evaluate the clinical value of monosomy 18, we obtained fluorescence in situ hybridization results (using centromeric probe for chromosome 18) of 22 MM patients who displayed a normal karyotype. Monosomy 18 was present in 3 of 22 patients (14%). Using conventional cytogenetics, we detected monosomy 18 in one patient affected with PCL. Two of four cases with monosomy 18 followed an aggressive course, with overall survival of 1 and 9 months. The remaining two are in follow-up and remain stable. The association of monosomy 18 with IgA subtype predominance and poor prognosis was not observed in this series of MMs and PCLs. Although these results do not confirm our previous hypothesis, further observations of this group of patients (with monosomy 18) regarding malignant transformation is warranted.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D007952 Leukemia, Plasma Cell A rare, aggressive variant of MULTIPLE MYELOMA characterized by the circulation of excessive PLASMA CELLS in the peripheral blood. It can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease. Leukemia, Plasmacytic,Plasma Cell Leukemia,Plasmacytic Leukemia,Leukemias, Plasma Cell,Leukemias, Plasmacytic,Plasma Cell Leukemias,Plasmacytic Leukemias
D009006 Monosomy The condition in which one chromosome of a pair is missing. In a normally diploid cell it is represented symbolically as 2N-1. Monosomies
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002887 Chromosomes, Human, Pair 18 A specific pair of GROUP E CHROMOSOMES of the human chromosome classification. Chromosome 18
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017404 In Situ Hybridization, Fluorescence A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei. FISH Technique,Fluorescent in Situ Hybridization,Hybridization in Situ, Fluorescence,FISH Technic,Hybridization in Situ, Fluorescent,In Situ Hybridization, Fluorescent,FISH Technics,FISH Techniques,Technic, FISH,Technics, FISH,Technique, FISH,Techniques, FISH

Related Publications

Elisabet Lloveras, and Isabel Granada, and Lurdes Zamora, and Blanca Espinet, and Lourdes Florensa, and Carles Besses, and Marisol Xandri, and Maria Encarnación Pérez-Vila, and Fuensanta Millà, and Soledad Woessner, and Francesc Solé
September 2000, Cancer genetics and cytogenetics,
Elisabet Lloveras, and Isabel Granada, and Lurdes Zamora, and Blanca Espinet, and Lourdes Florensa, and Carles Besses, and Marisol Xandri, and Maria Encarnación Pérez-Vila, and Fuensanta Millà, and Soledad Woessner, and Francesc Solé
May 2022, Scientific reports,
Elisabet Lloveras, and Isabel Granada, and Lurdes Zamora, and Blanca Espinet, and Lourdes Florensa, and Carles Besses, and Marisol Xandri, and Maria Encarnación Pérez-Vila, and Fuensanta Millà, and Soledad Woessner, and Francesc Solé
June 2007, Experimental oncology,
Elisabet Lloveras, and Isabel Granada, and Lurdes Zamora, and Blanca Espinet, and Lourdes Florensa, and Carles Besses, and Marisol Xandri, and Maria Encarnación Pérez-Vila, and Fuensanta Millà, and Soledad Woessner, and Francesc Solé
September 2012, Medical oncology (Northwood, London, England),
Elisabet Lloveras, and Isabel Granada, and Lurdes Zamora, and Blanca Espinet, and Lourdes Florensa, and Carles Besses, and Marisol Xandri, and Maria Encarnación Pérez-Vila, and Fuensanta Millà, and Soledad Woessner, and Francesc Solé
April 2005, Cancer genetics and cytogenetics,
Elisabet Lloveras, and Isabel Granada, and Lurdes Zamora, and Blanca Espinet, and Lourdes Florensa, and Carles Besses, and Marisol Xandri, and Maria Encarnación Pérez-Vila, and Fuensanta Millà, and Soledad Woessner, and Francesc Solé
September 1998, Cancer genetics and cytogenetics,
Elisabet Lloveras, and Isabel Granada, and Lurdes Zamora, and Blanca Espinet, and Lourdes Florensa, and Carles Besses, and Marisol Xandri, and Maria Encarnación Pérez-Vila, and Fuensanta Millà, and Soledad Woessner, and Francesc Solé
June 1997, Genes, chromosomes & cancer,
Elisabet Lloveras, and Isabel Granada, and Lurdes Zamora, and Blanca Espinet, and Lourdes Florensa, and Carles Besses, and Marisol Xandri, and Maria Encarnación Pérez-Vila, and Fuensanta Millà, and Soledad Woessner, and Francesc Solé
August 2004, Cancer genetics and cytogenetics,
Elisabet Lloveras, and Isabel Granada, and Lurdes Zamora, and Blanca Espinet, and Lourdes Florensa, and Carles Besses, and Marisol Xandri, and Maria Encarnación Pérez-Vila, and Fuensanta Millà, and Soledad Woessner, and Francesc Solé
August 1992, Annals of hematology,
Elisabet Lloveras, and Isabel Granada, and Lurdes Zamora, and Blanca Espinet, and Lourdes Florensa, and Carles Besses, and Marisol Xandri, and Maria Encarnación Pérez-Vila, and Fuensanta Millà, and Soledad Woessner, and Francesc Solé
January 2022, The Egyptian journal of medical human genetics,
Copied contents to your clipboard!